← SearchValidation of Spinal Neurotensin Receptor 2 as an Analgesic Target$1,461,204R01FY2020NSNIHUt Southwestern Medical Center, Dallas TXInvestigatorsAmol M PatwardhancontactLinked publications, trials & patentsPaper 35319982Paper 35050960Paper 33636371Paper 33591120Paper 33306248Paper 33155057Paper 32929856Paper 32903062View original record on NIH RePORTER →